Stockreport

Xilio Therapeutics Appoints Caroline Hensley as Chief Legal Officer

Xilio Therapeutics, Inc.  (XLO) 
PDF WALTHAM, Mass., Dec. 16, 2024 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activ [Read more]